Unlocking ACE2: The enzyme that links COVID-19, heart disease, and diabetes

A recent study in the Journal of Biomedical Science examines the critical role of ACE2, an enzyme involved in blood volume and electrolyte balance, in chronic diseases like cardiovascular conditions, diabetes, and COVID-19. The research suggests that ACE2 could serve as both a disease severity biomarker and a therapeutic target.

Related Keywords

,Kateryna Kon Shutterstock ,Biomedical Science ,Kateryna Kon ,Ace2 ,Hronic ,Coronavirus Disease Covid 19 ,Ngiotensin ,Ngiotensin Converting Enzyme 2 ,Flood ,Chronic Disease ,Coronavirus ,Diabetes ,Electrolyte ,Nzyme ,Gene ,Glycosylation ,Heart ,Lungs ,Pancreas ,Protein ,Jenin ,Espiratory ,Cars ,Ars Cov 2 ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Spike Protein ,Yndrome ,Thymus ,Ubiquitin ,Ascular ,Vitamin C ,